Anti-FRMD6/Willin antibody
4
(1 Review)
|
(3 Publications)
Rabbit Polyclonal FRMD6/Willin antibody. Suitable for IHC-P and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human FRMD6 aa 50-100 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
C14orf31, FRMD6, FERM domain-containing protein 6, Willin
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FRMD6/Willin antibody (AB218209)
Immunohistochemical analysis of formalin-fixed paraffin-embedded sections of human lung carcinoma tissue labeling FRMD6/Willin with ab218209 at a 1/200 dilution, followed by conjugation to a secondary antibody and DAB staining.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FRMD6 influences signaling pathways that regulate growth and differentiation. It contributes as part of a regulatory complex that communicates signals from the extracellular matrix to intracellular pathways. The protein is not known to be part of a stable complex but it interacts dynamically with several cytoskeletal elements during cell signaling events. It assists in transducing signals necessary for maintaining cellular architecture and function.
Pathways
FRMD6 is significantly involved in the Hippo signaling pathway which regulates cell proliferation and apoptosis. This pathway controls tissue growth and cancer development through interaction with proteins like YAP and TAZ. FRMD6 operates upstream within this pathway contributing to the suppression of cell growth by modulating these transcriptional coactivators.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy. Methods & clinical development 31:101144 PubMed38027058
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1160052 PubMed37404825
2023
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 56:95-110.e10 PubMed33207226
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com